- Home
- » Tags
- » Methotrexate
Top View
- Prophylaxis Guidelines for the Adult Hematology Patient
- Cyclophosphamide (IV)-Fluorouracil-Methotrexate (CMF
- CMF: Cyclophosphamide, Methotrexate and Fluorouracil
- Chemotherapy Extravasation Management
- Subcutaneous Administration of Anticancer Agents
- Methotrexate Class:Antimetabolite (Antifolate) Indications : Acute
- Antifolate Pseudo-Resistance Due to Elevated Levels of Thymidine and Hypoxanthine in a Commercial Serum Preparation
- Methotrexate 25Mg/Ml Solution for Injection - Summary of Product Characteristics (SPC) - (Emc)
- PATIENT FACT SHEET (Rheumatrex, Trexall, Otrexup, Rasuvo)
- CELEBREX Safely and Effectively
- CELEBREX (Sell-E-Brecks) Celecoxib (Sell-E-Cox-Ib) Consumer Medicine Information
- Pyrimidine-Based Antifolate That Inhibits Multiple Folate-Requiring Enzymes
- Preoperative Guidelines for Medications Prior to Surgery
- Methotrexate and Pregnancy
- Improved Bioavailability and High Photostability of Methotrexate by Spray-Dried Surface-Attached Solid Dispersion with an Aqueous Medium
- Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate
- Initial Protocol
- Mtor Inhibitors: a Novel Class of Anti-Cancer Agents Haris Riaz1,2, Talha Riaz1 and Syed a Hussain3*
- Breast Cancer Using Metronomic Low-Dose Oral Cyclophosphamide and Methotrexate
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014
- Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel
- Auxiliary Label List
- Oral Methotrexate Other Than Cancer)
- Leflunomide: Mode of Action in the Treatment of Rheumatoid Arthritis
- Schedule-Dependent Synergism and Antagonism Between Methotrexate
- Mavenclad, INN-Cladribine
- Primary CNS Lymphoma)
- Trisenox, INN-Arsenic Trioxide
- Methotrexate Drug Information
- Pharmacological and Therapeutics Agents That Target DNA Replication by Yves Pommier M.D., Ph.D.1 and Robert B
- ATC/DDD Classification WHO Drug Information Vol
- Sirolimus Induces Apoptosis and Reverses Multidrug Resistance in Human Osteosarcoma Cells in Vitro Via Increasing Microrna-34B Expression
- Methotrexate for Ectopic Pregnancy – July 2017 Page 1 of 2
- Anti-Rheumatic Activity of Celecoxib and Methotrexate in Collagen
- Prognosticfactors in Patientswith Advancedstage Prostatecancer1
- Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2
- Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings
- Chemotherapy Drugs
- Guidelines for ATC Classification and DDD Assignment 2011
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- Alimta, INN-Pemetrexed
- Arsenic Trioxide Replacing Or Reducing Chemotherapy in Consolidation Therapy for Acute Promyelocytic Leukemia (APL2012 Trial)
- BC Cancer Protocol Summary for Treatment of Lymphoma Using Intrathecal Methotrexate and Cytarabine
- Extending Practical (In-Use) Shelf Life of Drug Vials with the Tevadaptor
- Guidelines for Atcvet Classification 2013
- The Evolving Role of Mtor Inhibition in Transplantation Tolerance
- Draft Guidelines for the Identification of Beneficiaries with Risk Factors in Accordance with the Entry and Verification Criteria
- Cladribine Injection Kinase and Low Deoxynucleotidase Activities Will Be Selectively Killed by 2-Chloro-2΄-Deoxy- Cells Remain in the Bone Marrow
- Marine-Derived Natural Products As ATP-Competitive Mtor Kinase Inhibitors for Cancer Therapeutics
- 1 Mtorc1 Inhibition Induces Resistance To
- Reference ID: 4526395
- Material Safety Data Sheet
- High Dose Methotrexate and Cytarabine
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
- Physician Orders Chemotherapy: Methotrexate + Leucovorin + Cytarabine (Hyper-Cvad, Even Cycle)
- Smart Battles: Immunosuppression Versus Immunomodulation in The
- ALTERATIONS in ATC CLASSIFICATION/ Valid from January 2017 Sorted According to Previous ATC Code
- Mtorc1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Phþ and Ph-Like B-ALL Thanh-Trang T
- R-HD Methotrexate & Cytarabine
- Agrylin® Capsules
- Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid
- Ltd Page 1 of 14 Celebrex 100 and 200 Capsules Final Approved PI – 28 July 2020
- Methotrexate Tablets, Usp
- Immunosuppressive Drugs and Fertility
- Palliative Chemotherapy for Recurrent and Metastatic Esophageal Cancer
- The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer
- Methotrexate an Old Drug with New Tricks
- Radiation Recall Phenomenon Associated with Arsenic Trioxide
- Antifolate Polyglutamylation and Competitive Drug Displacement at Dihydrofolate ReducãAseas Important Elements in Leucovorin Rescue in L1210 Cells1
- Overview of Dual-Acting Drug Methotrexate in Different
- Breast Pathway Group – Oral Cyclophosphamide & Methotrexate
- Combination of Cladribine and Cytarabine Is Effective for Childhood Acute Myeloid Leukemia: Results of the St Jude AML97 Trial
- Trisenox,INN-Arsenic Trioxide